Fate Therapeutics Reports Third Quarter 2020 Financial Results and Highlights Operational Progress

NEXT STORY
Coherus BioSciences Reports Third Quarter 2020 Financial Results
PREV STORY
Inventiva announces the appointment of Dr. Michael Cooreman as Chief Medical Officer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

DIAGNOS announces a 3-year partnership agreement with the University of Montreal Hospital Centre (CHUM) on the use of Artificial Intelligence

author_avatar
NASDAQ Market News

Delcath Systems Schedules Conference Call to Report 2021 Second Quarter Financial Results

author_avatar
NASDAQ Market News

Trillium Therapeutics Appoints Dr. Ingmar Bruns as Chief Medical Officer

author_avatar
NASDAQ Market News